scholarly journals HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support

2001 ◽  
Vol 27 (8) ◽  
pp. 847-853 ◽  
Author(s):  
M Bewick ◽  
M Conlon ◽  
S Gerard ◽  
H Lee ◽  
AM Parissenti ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
Metastatic Breast Cancer ◽  
Prognostic Factor ◽  
Autologous Blood ◽  
Metastatic Breast ◽  
High Dose ◽  
Stem Cell Support ◽  
Her 2 ◽  
Cell Support

High-Dose Taxol, Cyclophosphamide, and Cisplatin with Stem Cell Support in the Treatment of Metastatic Breast Cancer

1998 ◽  
Vol 4 (3) ◽  
pp. 165-170
Author(s):  
Svetislava J. Vukelja ◽  
W. Jeffery Baker ◽  
Miriam Y.J. Atkins ◽  
Nicole Lee ◽  
Joseph J. Stephenson
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
High Dose ◽  
Stem Cell Support ◽  
Cell Support

scholarly journals High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer

1997 ◽  
Vol 20 (3) ◽  
pp. 199-203 ◽  
Author(s):  
P Viens ◽  
G Gravis ◽  
D Genre ◽  
F Bertucci ◽  
D Cowen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
High Dose ◽  
Sequential Chemotherapy ◽  
Stem Cell Support ◽  
Cell Support
Sign in / Sign up

Export Citation Format

Share Document